AI assistant
INSMED Inc — Director's Dealing 2023
May 17, 2023
30150_dirs_2023-05-17_7b829f4f-7e56-49cc-991e-73bef4e02138.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-05-15
Reporting Person: Flammer Martina M.D. (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-15 | Common Stock | S | 2576 | $19.28 | Disposed | 116624 | Direct |
| 2023-05-16 | Common Stock | S | 1718 | $18.43 | Disposed | 114906 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.
F2: This is the weighted average sales price representing 2,576 shares sold at prices ranging from $19.27 to $19.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 1,718 shares sold at prices ranging from $18.43 to $18.47 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.